LBRX · Lb Pharmaceuticals Inc · Exempt Offerings
Market Cap
$1.44B
Shares
32.26M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2024-01-10 | Amendment | Pharmaceuticals | $110,730,354 | $110,730,354 | 06b |
| 2023-09-21 | New | Pharmaceuticals | $110,730,354 | $70,730,354 | 06b |
| 2022-11-23 | Amendment | Pharmaceuticals | $40,000,000 | $16,574,000 | 06b |
| 2022-11-01 | New | Pharmaceuticals | $10,000,000 | $6,925,000 | 06b |
| 2022-07-06 | New | Pharmaceuticals | Indefinite | $903,350 | 06b |
| 2020-09-01 | New | Pharmaceuticals | $10,000,000 | $4,629,200 | 06b |
Showing 1–6 of 6 filings
Key facts
CIK
1691082
CUSIP
50180M108
13F (30d)
51 filings
51 filers
Visit website
Investor relations